Kanglong Chemical (03759) plans to sell its shares in Proteologix Investments and is expected to receive an initial payment of approximately US$86.821 million
Kanglong Chemical (03759) issued an announcement regarding the sale of the Group's interest in PROTEOLOGIX, INC.
Kanglong Chemical (03759) spent 128 million yuan to buy back 5.826,500 A shares on May 17
Kanglong Chemical (03759) announced that on May 17, 2024, the company spent 128 million yuan to buy back...
Kanglong Chemical (03759) will distribute the 2023 final dividend of 2 yuan for every 10 shares on July 26
Kanglong Chemical (03759) announced that the company will distribute the end of 2023 on July 26, 2024...
NOTICE OF THE ANNUAL GENERAL MEETING OF 2023
Intraday Overview | Tech Index rose more than 1%, and TechNet stocks were trending strongly. Bilibili rose more than 6%; Tencent Music rose more than 9% after its performance
Technology Network stocks rose collectively, with Bilibili up more than 6%, Kuaishou and Xiaomi Group up more than 3%; auto stocks improved, Great Wall Motor rose more than 7%, NIO rose nearly 6%, and Zero Sports Auto rose nearly 5%.
Express News | Galaxy Securities: Judging from the pace of the industry's revenue growth rate, the first quarter of 2024 is expected to be the lowest point in the pharmaceutical industry in the whole year
Intraday quick overview | The Science Index rose more than 1% to reach the 4,000 mark; port transport stocks were strong, and COSCO Marine Control rose more than 6%
Water stocks soared across the board. China Water Services rose more than 9%, Beijing Water Group rose more than 8%; high-speed rail infrastructure stocks collectively rallied, CRRC rose more than 9%, and Times Electric rose nearly 7%.
CRO concept stocks opened and surged. Baihua Pharmaceuticals rose and stopped. Wanbang Pharmaceuticals rose more than 17%, Pharmaceutical Kangde rose more than 8%, and Kanglong Chemical, Gloria Ying, and Tiger Pharmaceuticals all opened higher.
CRO concept stocks opened and surged. Baihua Pharmaceuticals rose and stopped. Wanbang Pharmaceuticals rose more than 17%, Pharmaceutical Kangde rose more than 8%, and Kanglong Chemical, Gloria Ying, and Tiger Pharmaceuticals all opened higher.
The medical news is huge! Will Pharmacokinetics usher in a turning point? US pharmaceutical company contract exemption or extension for 8 years
Industry insiders believe that 8 years is enough time for relevant companies to adapt, and the implementation of this greatest uncertainty can also have a positive impact on related companies.
Kanglong Chemical (300759): 2024Q1 new orders grow 20% + all businesses maintain steady development
Incident Summary The company announced its results report for the first quarter of 2024 on April 25, 2024. 2024Q1 achieved revenue of 2,671 billion yuan, a year-on-year decrease of 1.95%; net profit to mother was 231 million yuan.
Kanglong Chemical (300759) Comment: Short-term performance under pressure, optimistic about annual growth
Event: The company released its 2024 quarterly report. 2024Q1 achieved operating income of 2,671 billion yuan, a year-on-year decrease of 1.95%, realized net profit to mother of 231 million yuan, a year-on-year decrease of 33.80%, and realized non-net profit deduction
Changes in Hong Kong stocks | Pharmaceutical Biotech (02269) rose more than 5%, leading the CRO concept financing environment, which is expected to improve the market and continue to monitor the progress of the Aesthetic Biology Act
CRO concept stocks generally rose in early trading. As of press release, Pharmaceuticals (02269) rose 4.67% to HK$14.78; Kanglong Chemical (03759) rose 4.15% to HK$10.28; Pharmaceuticals (02359) rose 3.02% to HK$37.5; and Tiger Pharmaceuticals (03347) rose 2.58% to HK$35.8.
May 8 Repurchase Collection | Hang Seng Bank, Swire Group A and others bought back one after another. Of these, Hang Seng Bank spent HK$32.0953 million
According to documents disclosed by the Hong Kong Stock Exchange on May 9, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 300,000 common shares on May 8, involving an amount of HK$32.0953 million. The repurchase price per share ranged from HK$107.7 to HK$106. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 300,000 shares, accounting for 0.016% of the number of shares issued when the ordinary resolution was passed. ② $Swire Group A
Kanglong Chemical (300759.SZ): Initial repurchase of 250,000 shares involving 4.9874 million yuan
Gelonghui, May 8, 丨 Kanglong Huacheng (300759.SZ) announced that on May 8, 2024, the company used its own funds to repurchase shares through centralized bidding transactions for the first time through a special stock repurchase securities account. The number of shares repurchased was 250,000 shares, accounting for 0.01% of the company's current total share capital (1,787,394,297 shares). The highest transaction price of the repurchase was 19.99 yuan/share, and the total transaction amount was 49,874.33 million yuan (excluding transaction fees).
Kanglong Chemical (03759.HK) spent 4.987 million yuan to buy back 250,000 A shares on May 8
Gelonghui, May 8, 丨 Kanglong Chemical (03759.HK) announced that it spent 4.987 million yuan to buy back 250,000 A-shares on May 8, 2024.
Kanglong Chemical (03759.HK) spent 4.9874 million yuan to buy back 250,000 A shares on May 8
Kanglong Chemical (03759.HK) announced that on May 8, 2024, the company spent 4.9874 million yuan to repurchase 250,000 A shares at a repurchase price of HK$19.92-19.99 per share.
Kanglong Chemical (03759) spent 4.9874 million yuan to buy back 250,000 A shares on May 8
Kanglong Chemical (03759) announced that on May 8, 2024, the company spent 4.9874 million yuan to return...
Express News | Kanglong Chemical: No share repurchases have been made as of the end of April
Kanglong Chemical (300759.SZ): The company did not repurchase shares
Gelonghui, May 7, 丨 Kanglong Chemical (300759.SZ) announced that during the period from April 26, 2024 to April 30, 2024 (a total of three trading days), the company did not repurchase shares.
Express News | Guotai Junan: Pharmaceutical industry prosperity is expected to continue to improve
No Data